Home › Pulmonary Hypertension › Minnesota
Pulmonary Hypertension clinical trials in Minnesota
8 studies for Pulmonary Hypertension are looking for participants at sites in Minnesota.
Cities in Minnesota
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Minneapolis Heart Institute, Minneapolis
- Mayo Clinic, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06526195Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Minnesota, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Mayo Clinic - Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Real World Observational Study of Sotatercept for Pulmonary Hypertension
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 6, 2026 · NCT06751082Pulmonary Hypertension in Left Heart Disease
- Mayo Clinic in Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT05935605CVD/PH and Voice Characteristics
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 30, 2025 · NCT07311044Pulmonary Hypertension Association Registry
- University of Minnesota Health, Minneapolis
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Sep 29, 2025 · NCT04555161From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.